I predict AbCellera Biologics (ABCL) hits $11.00 by Aug 28, 2026
17 days remaining
Analysis
Abcellera is bio technology company which works mainly on anti body drugs and they have their own internal drug medicine to work on. ABCL635, new drug treatment experimental antibody treatment for menopausal hot flashes and vasomotor symptoms. The Phase 2 results were very encouraging: Good reduction in hot flashes/night sweats Improvement in sleep and well being They treated 92 patients and they are no discontinues. Potential for once-monthly dosing The market reacted strongly because the results suggest ABCL635 could potentially compete with existing and non hormonal menopause treatments.
Price Tracking
When Guessed
$9.3400
Aug 11, 2026
Movement
▲ +0.00%
Last Updated
$9.3400
Aug 11
More in Healthcare
More USD market predictions
Agree · Bullish
Disagree · Bearish